# Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy

> **NCT07716930** · — · ENROLLING_BY_INVITATION · sponsor: **Kemal Tutkavul** · enrollment: 250 (estimated)

## Conditions studied

- Epilepsy (Treatment Refractory)
- Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07716930
- **Lead sponsor:** Kemal Tutkavul
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-07-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-07-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07716930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07716930, "Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07716930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*